Diabetes mellitus Posts Page 2 on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Risk factors associated with nonalcoholic fatty liver disease in patients with type 2 diabetes

Posted by on Dec 30, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the occurrence of nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes (T2D). The main finding of the study was that T2D patients who are older, who smoke and have high body weight and diastolic blood pressure are more likely to develop NAFLD. Some background T2D is commonly...

Read More

Can non-insulin diabetic drugs benefit overweight adults with type 1 diabetes?

Posted by on Dec 24, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to see if non-insulin diabetic drugs could improve weight loss and blood glucose control in patients with type 1 diabetes (T1D). The main finding of the study was that non-insulin diabetic drugs may be of some benefit to overweight patients with T1D. Some background T1D is treated with insulin. However, the side effects...

Read More

Can good blood glucose control stop the stiffening of blood vessels in patients with diabetes?

Posted by on Dec 23, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate if optimal blood glucose control reduces the stiffening (calcification) of the arteries of the heart in patients with diabetes. The main finding of the study was that optimal blood sugar control stopped the calcification of the arteries of the heart. Some background Calcifications appear when...

Read More

Is there a better time to reduce basal insulin before exercise to prevent hypoglycemia?

Posted by on Dec 22, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to compare three different times to decrease basal insulin to reduce hypoglycemia after exercise in patients with type 1 diabetes. The main finding of the study was that reducing basal insulin by 80% up to 40 minutes before exercise still did not reduce exercise-induced hypoglycemia. Some background Insulin is...

Read More

Does diabetes in a woman increase the risk of attention deficit/hyperactivity disorder in their child?

Posted by on Dec 22, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to examine if diabetes in a woman increases the risk of attention-deficit/hyperactivity disorder (ADHD) in their child. The main finding of the study was that there was in an increased risk of ADHD in a child when the mother had diabetes that required medication. Some background There are three main types...

Read More

Lower fat diet associated with diabetic eye disease in type 1 diabetes

Posted by on Dec 12, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to look at the differences in the diets of people with type 1 diabetes (T1D) with and without diabetic retinopathy (DR; eye damage). The main finding of the study was that a higher fat intake was associated with lower frequency of DR. Some background DR is a type of eye disease that can occur in patients with T1D. If it...

Read More

The effect of drugs that protect nerves in the early stage of diabetic eye disease

Posted by on Dec 11, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to assess whether giving drugs that protect nerves (brimonidine and somatostatin) into the eye can prevent or stop nerve damage in the eye of patients with type 2 diabetes (T2D). The main finding of this study was these drugs protected patients with nerve damage in the eye from the disease worsening. Some...

Read More

How effective is self-management with empagliflozin in the treatment of type 2 diabetes?

Posted by on Dec 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to see how effective intermittent use of empagliflozin (Jardiance) controlled by the patients is in the treatment of poorly controlled type 2 diabetes (T2D). The main finding of the study was that intermittent use of empagliflozin controlled blood sugars as effectively as those who take it every day. Some background...

Read More

DPP-4 inhibitor use in type 2 diabetes and the risk of diabetic eye disease

Posted by on Dec 8, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study aimed to investigate if the use of DPP-4 inhibitor drugs for the treatment of type 2 diabetes (T2D) was harmful or helpful in diabetic retinopathy (DR; eye disease). The main finding of this study was that DPP-4 inhibitors did not increase the overall risk of DR. Some background DPP-4 inhibitors (DPP4i) are a type drug used to...

Read More

Insulin or enhanced oral anti-diabetic tablet therapy in uncontrolled type 2 diabetes?

Posted by on Dec 5, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the effects of starting insulin therapy versus enhancing oral tablet therapy after failure with three oral anti-diabetic (OAD) tablets in patients with type 2 diabetes (T2D). The main finding of the study was that adding insulin after failure with three OADs was effective, however, it increased...

Read More

The effect of canagliflozin on fatty liver disease and insulin production in patients with type 2 diabetes

Posted by on Dec 1, 2018 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to investigate the effect of canagliflozin (Invokana) on insulin secretion and action along with changes in liver fat deposits and weight loss in patients with type 2 diabetes (T2D). The main finding of the study was that canagliflozin improved insulin secretion and usage, increased weight loss and...

Read More